AstraZeneca is putting the pedal to the metal to drive up early detection of prostate cancer. | AstraZeneca is putting the ...

Following the presentation titled ‘Discovering Targeted Glue™ degraders with Amphista's Eclipsys® platform’, Simon Gilbert, PhD, Presenting Author and Associate Director Discovery Biology at Amphista ...

Procter & Gamble, Nestlé, Apple, L'Oréal, Novartis, LG Electronics and Unilever among the largest portfolio owners in most registers LONDON, May 15, 2025 /PRNewswire/ -- Clarivate Plc ...

Tensions rise in Korea's pharma sector as Trump plans drug tariffs. Companies like Samsung Biologics monitor the situation while the government opposes potential U.S. measures.

LONDON (Reuters) -Swiss drugmaker Novartis will keep making medicines for malaria and leprosy, even if it does not get orders ...

Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion, giving the Swiss drugmaker access to an experimental ...

Applications are now being accepted, with $500,000 in grants to be awarded to projects focused on improving health equity in Canada Novartis Pharmaceuticals Inc. (CNW Group/Novartis Pharmaceuticals ...

Swiss pharmaceutical giant Novartis (SIX:NOVN) has reaffirmed its commitment to producing life-saving treatments for malaria ...

Squeezed by insurers and middlemen, independent pharmacists find themselves on the front lines of a tariff storm.

FRANKFURT, April 29 (Reuters) - Novartis (NOVN.S), opens new tab released a more optimistic full-year earnings forecast on Tuesday, citing the strong growth of drugs such as Leqvio, Kisqali and ...